Table 4 Results for Pearson's correlation analysis between FA, AD and RD values of the gCC and bCC and SLC6A4 methylation (CpG1, CpG2, CpG3, CpG4 and CpG5) in drug naive MDD patients and healthy controls
SLC6A4 methylation | |||||
|---|---|---|---|---|---|
CpG1 | CpG2 | CpG3 | CpG4 | CpG5 | |
FA | |||||
MDD patients | |||||
gCC | −0.068 (0.702) | −0.195 (0.27) | −0.28 (0.108) | −0.253 (0.15) | −0.132 (0.458) |
bCC | −0.301 (0.084) | −0.255 (0.15) | −0.493 (0.003)a | −0.438 (0.01)b | −0.142 (0.422) |
Healthy controls | |||||
gCC | −0.191 (0.192) | −0.17 (0.249) | −0.203 (0.167) | −0.372 (0.009)a | −0.095 (0.519) |
bCC | −0.022 (0.88) | −0.03 (0.840) | −0.042 (0.778) | −0.117 (0.428) | 0.013 (0.931) |
AD | |||||
MDD patients | |||||
gCC | −0.188 (0.288) | −0.315 (0.07) | −0.419 (0.14) | −0.361 (0.036) | −0.301 (0.084) |
bCC | −0.225 (0.2) | −0.252 (0.151) | −0.478 (0.004)a | −0.341 (0.049) | −0.293 (0.092) |
Healthy controls | |||||
gCC | 0.215 (0.143) | −0.139 (0.345) | −0.101 (0.493) | 0.201 (0.170) | −0.042 (0.779) |
bCC | 0.024 (0.872) | 0.012 (0.938) | 0.068 (0.647) | 0.082 (0.577) | −0.080 (0.587) |
RD | |||||
MDD patients | |||||
gCC | 0.034 (0.847) | 0.124 (0.486) | 0.190 (0.282) | 0.168 (0.341) | 0.042 (0.815) |
bCC | 0.237 (0.178) | 0.156 (0.378) | 0.307 (0.077) | 0.294 (0.092) | 0.021 (0.907) |
Healthy controls | |||||
gCC | 0.200 (0.173) | 0.153 (0.298) | 0.175 (0.234) | 0.388 (0.006)a | 0.064 (0.664) |
bCC | 0.028 (0.850) | 0.041 (0.780) | 0.022 (0.883) | 0.107 (0.470) | −0.041 (0.783) |